EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SNRNP70 regulates the splicing of CD55 to promote osteosarcoma progression

Wenyue Li, Linzhu Wang, Wen Tian, Weihang Ji, Danyang Bing, Yan Wang, Bingqian Xu, Jiayue Feng, Peng Zhang, Haihai Liang, Yunyan Gu, Baofeng Yang

JCI Insight · 2024

DOI: 10.1172/jci.insight.185269 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCI Insight, 2024. Verfasst von Wenyue Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China. Hauptthemen laut MEDLINE: Osteosarcoma, Disease Progression, Bone Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Key Research and Development Program of China,the National Science Foundation of China,and the Scientific Fund Project of Heilongjiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteosarcoma (OS) is the most common malignant bone tumor, characterized by a high propensity for metastasis. Recent studies have highlighted the role of alternative splicing in cancer metastasis, although the precise mechanisms underlying aberrant splicing in OS invasion and metastasis remain unclear. Here, we analyzed consistently differentially expressed genes and differentially alternative splicing events between primary and metastatic OS to identify potential genes associated with OS progression. U1 small nuclear ribonucleoprotein 70K ( SNRNP70 ) emerged as both differentially expressed and spliced, with elevated SNRNP70 levels correlating with poor prognosis in pateints with OS. Functional experiments demonstrated that SNRNP70 overexpression enhanced the proliferation and metastasis of OS cells in vitro, while its depletion reduced these capabilities in vivo. Mechanistically, SNRNP70 directly interacted with CD55 , modulating its alternative splicing and promoting tumor progression in OS. Additionally, metastatic OS samples exhibited increased infiltration of resting immune cells, and single-cell RNA sequencing revealed communication between SNRNP70 -expressing osteoblastic cells and macrophages via the ADGRE5/CD55 signaling pathway. Overall, our results showed that SNRNP70 knockdown inhibited OS progression, which was associated with the splicing of CD55 , indicating SNRNP70 as a promising target for OS treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteosarcomaDisease ProgressionBone NeoplasmsHumansMiceAnimalsCell Line, TumorAlternative SplicingRibonucleoprotein, U1 Small NuclearGene Expression Regulation, NeoplasticCell ProliferationMaleFemale

Stichwörter der Autor:innen

Cell biologyMolecular biologyOncogenesOncology

Substanzen

SNRNP70 protein, humanRibonucleoprotein, U1 Small Nuclear

Autor:innen und Institutionen

  • Department of Pharmacy, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.
  • Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), State Key Laboratory of Frigid Zone Cardiovascular Di…
  • Bone and Soft Tissue Sarcoma, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan Province, China.
  • Department of Nephrology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China.
  • Research Unit of Noninfectious Chronic Diseases in Frigid Zone, Chinese Academy of Medical Sciences, Harbin, Heilongjiang Province, China.
  • Department of Systems Biology, College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, Heilongjiang Province, China.

Förderung

  • the National Key Research and Development Program of China,the National Science Foundation of China,and the Scientific Fund Project of Heilongjiang Province

Zitieren

APA

Li, W., Wang, L., Tian, W., Ji, W., Bing, D., Wang, Y., Xu, B., Feng, J., Zhang, P., Liang, H., Gu, Y., & Yang, B. (2024). SNRNP70 regulates the splicing of CD55 to promote osteosarcoma progression. JCI Insight. https://doi.org/10.1172/jci.insight.185269

Vancouver

Li W, Wang L, Tian W, Ji W, Bing D, Wang Y, et al. SNRNP70 regulates the splicing of CD55 to promote osteosarcoma progression. JCI Insight. 2024. doi:10.1172/jci.insight.185269

BibTeX
@article{Li2024,
  author = {Li, Wenyue and Wang, Linzhu and Tian, Wen and Ji, Weihang and Bing, Danyang and Wang, Yan and Xu, Bingqian and Feng, Jiayue and Zhang, Peng and Liang, Haihai and Gu, Yunyan and Yang, Baofeng},
  title = {SNRNP70 regulates the splicing of CD55 to promote osteosarcoma progression},
  journal = {JCI Insight},
  year = {2024},
  doi = {10.1172/jci.insight.185269}
}
Kostenlos starten →